Literature DB >> 3106698

Fibrillary glomerulonephritis: an entity with unusual immunofluorescence features.

C E Alpers, H G Rennke, J Hopper, C G Biava.   

Abstract

We describe seven patients with renal biopsy findings of mild glomerular abnormalities on light microscopy but with prominent accumulation of randomly-arranged fibrillar material in the mesangium and capillary walls on electron microscopy. This material differed from amyloid in that fibrils were thicker (diameter range 10 to 19.5 nm) and did not stain with Congo Red. In six of seven cases fluorescence microscopy showed prominent staining for IgG and kappa light chain in mesangium and glomerular capillary walls; in three cases weak lambda chain staining was also present. Stains for IgA, IgM, and lambda chain were otherwise negative. One biopsy showed equal staining for kappa and lambda light chains, but not for heavy chain components. Clinical findings were heterogeneous. Patients presented with features of nephritis and/or nephrotic syndrome. No patient had an associated lymphoplasmacytic disorder, paraproteinemia, or other evidence of systemic disease. On follow-up ranging from five months to 12 years, all patients are still alive; six progressed to end-stage renal disease requiring dialysis. One patient developed recurrent disease in a renal allograft five years after transplantation. Non-amyloidotic fibrillary glomerulonephritis is an ultrastructurally distinct entity of undetermined etiology. The apparent association with monoclonal IgG and kappa light chain deposition observed in this series deserves further study.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106698     DOI: 10.1038/ki.1987.66

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  27 in total

1.  Fibrillary glomerulonephritis.

Authors:  Wako Yumura
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

2.  Non-Hodgkin's lymphoma associated membranoproliferative glomerulonephritis: rare case of long term remission with chemotherapy: a case report.

Authors:  Hala Alshayeb; Barry M Wall
Journal:  Cases J       Date:  2009-09-15

3.  Fibrillary glomerulonephritis: a report of 66 cases from a single institution.

Authors:  Samih H Nasr; Anthony M Valeri; Lynn D Cornell; Mary E Fidler; Sanjeev Sethi; Nelson Leung; Fernando C Fervenza
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 8.237

4.  Fibrillary Glomerulonephritis: Clinicopathologic Features and Atypical Cases from a Multi-Institutional Cohort.

Authors:  Nicole K Andeen; Megan L Troxell; Maziar Riazy; Rupali S Avasare; Jessica Lapasia; J Ashley Jefferson; Shreeram Akilesh; Behzad Najafian; Roberto F Nicosia; Charles E Alpers; Kelly D Smith
Journal:  Clin J Am Soc Nephrol       Date:  2019-11-04       Impact factor: 8.237

5.  DnaJ Homolog Subfamily B Member 9 Is a Putative Autoantigen in Fibrillary GN.

Authors:  Nicole K Andeen; Han-Yin Yang; Dao-Fu Dai; Michael J MacCoss; Kelly D Smith
Journal:  J Am Soc Nephrol       Date:  2017-11-02       Impact factor: 10.121

Review 6.  Nonamyloidotic fibrillary glomerulopathy. Report of a case and review of the literature.

Authors:  A Billis; E Homsi
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

7.  The gene for human fibronectin glomerulopathy maps to 1q32, in the region of the regulation of complement activation gene cluster.

Authors:  M Vollmer; M Jung; F Rüschendorf; R Ruf; T Wienker; A Reis; R Krapf; F Hildebrandt
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

8.  Immunotactoid glomerulopathy in a child with Down syndrome.

Authors:  T Takemura; K Yoshioka; N Akano; I Michihata; M Okada; S Maki; H Shigematsu
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

Review 9.  Renal replacement therapy in multiple myeloma and systemic amyloidosis.

Authors:  J H Brown; C C Doherty
Journal:  Postgrad Med J       Date:  1993-09       Impact factor: 2.401

10.  Fever of unknown origin secondary to type I crescentic glomerulonephritis and anti-SCl 70 antibodies without clinical manifestations of systemic sclerosis.

Authors:  Jorge Vega Stieb; Helmuth Goecke Saavedra; Gonzalo Méndez Olivieri
Journal:  Clin Exp Nephrol       Date:  2008-05-20       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.